美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
68382-523-05	68382-523	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	325 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-523-05)
68382-523-14	68382-523	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	325 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-523-14)
68382-524-05	68382-524	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	425 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-524-05)
68382-524-14	68382-524	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	425 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-524-14)
68382-522-14	68382-522	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	225 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-522-14)
68382-522-05	68382-522	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	225 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-522-05)
70771-1526-6	70771-1526	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	325 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-6)
70771-1527-5	70771-1527	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	425 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1527-5)
70771-1527-6	70771-1527	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	425 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1527-6)
70771-1525-6	70771-1525	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	225 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-6)
70771-1525-5	70771-1525	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	225 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-5)
70771-1526-5	70771-1526	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride	Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202	N/A	ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	325 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-5)